_id
69105ba3ccc777a4e85d580c
Ticker
DMAA
Name
Drugs Made In America Acquisition Corp. Ordinary Shares
Exchange
NASDAQ
Address
1 East Broward Boulevard, Fort Lauderdale, FL, United States, 33301
Country
USA
Sector
Financial Services
Industry
Shell Companies
Currency
USD
Website
https://dmaacorp.com
Description
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Last Close
10.374
Volume
-
Current Price
10.37
Change
-0.09643201542912042
Last Updated
2026-01-02T12:40:23.729Z
Image
data:image/webp;base64,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
Ipo Date
2025-02-25T00:00:00.000Z
Market Cap
347713536
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
263703
Operating Income
-263703
Interest Expense
-
Pretax Income
2184563
Net Income
2184563
Eps
0.094981
Dividends Per Share
-
Shares Outstanding
33517143
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
2448266
Cash
717
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
28196
Property Plant Equipment
-
Total Assets
237632428
Payables
302623
Short Term Debt
-
Long Term Debt
-
Total Liabilities
7356611
Equity
-7328415
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
82293
Cash From Operations
137908
Capital Expenditures
4
Cash From Investing
231150000
Cash From Financing
-231303588
Net Change In Cash
-105
Cf_currency_symbol
USD
PE
-
PB
-32.54591886512977
ROE
-29.80948813624774
ROA
0.919303404163341
FCF
137904
Fcf Percent
-
Piotroski FScore
2
Health Score
39
Deep Value Investing Score
5
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
8.3
Garp Investing Score
4.5
Growth Investing Score
4.5
Momentum Investing Score
3.5
Net Net Investing Score
2
Quality Investing Score
4.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
263703
Quarters > 0 > income Statement > operating Income
-263703
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
2184563
Quarters > 0 > income Statement > net Income
2184563
Quarters > 0 > income Statement > eps
0.094981
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
23000000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
2448266
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
717
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
28196
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
237632428
Quarters > 0 > balance Sheet > payables
302623
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
7356611
Quarters > 0 > balance Sheet > equity
-7328415
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
785092
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
82293
Quarters > 0 > cash Flow > cash From Operations
137908
Quarters > 0 > cash Flow > capital Expenditures
4
Quarters > 0 > cash Flow > cash From Investing
231150000
Quarters > 0 > cash Flow > cash From Financing
-231303588
Quarters > 0 > cash Flow > net Change In Cash
-105
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.094981
Quarters > 0 > ratios > PB
-32.54591886512977
Quarters > 0 > ratios > ROE
-29.80948813624774
Quarters > 0 > ratios > ROA
0.919303404163341
Quarters > 0 > ratios > FCF
137904
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
131919
Quarters > 1 > income Statement > operating Income
-131919
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
2288579
Quarters > 1 > income Statement > net Income
2288579
Quarters > 1 > income Statement > eps
0.0682808495938929
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
33517143
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-131919
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
2420498
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
822
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
49726
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
235205692
Quarters > 1 > balance Sheet > payables
147453
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
7201441
Quarters > 1 > balance Sheet > equity
228004251
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
3688050
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-67400
Quarters > 1 > cash Flow > cash From Operations
-300671
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-231150000
Quarters > 1 > cash Flow > cash From Financing
231466145
Quarters > 1 > cash Flow > net Change In Cash
-1273
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.0682808495938929
Quarters > 1 > ratios > PB
1.524413564157626
Quarters > 1 > ratios > ROE
1.0037440047554202
Quarters > 1 > ratios > ROA
0.9730117415695875
Quarters > 1 > ratios > FCF
-300671
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
59
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
330925
Quarters > 2 > income Statement > operating Income
-330925
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
1254543
Quarters > 2 > income Statement > net Income
1254543
Quarters > 2 > income Statement > eps
0.04918184521763034
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
25508254
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-330925
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1585468
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
923
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
71019
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
232806487
Quarters > 2 > balance Sheet > payables
132483
Quarters > 2 > balance Sheet > short Term Debt
60898
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
7247369
Quarters > 2 > balance Sheet > equity
225559118
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
1254543
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-14893
Quarters > 2 > cash Flow > cash From Operations
-251244
Quarters > 2 > cash Flow > capital Expenditures
4
Quarters > 2 > cash Flow > cash From Investing
-231150000
Quarters > 2 > cash Flow > cash From Financing
231400816
Quarters > 2 > cash Flow > net Change In Cash
-428
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.04918184521763034
Quarters > 2 > ratios > PB
1.1727328796346863
Quarters > 2 > ratios > ROE
0.55619254549488
Quarters > 2 > ratios > ROA
0.538878025336124
Quarters > 2 > ratios > FCF
-251248
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
58
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
279.88
Quarters > 3 > income Statement > operating Income
-279
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-279
Quarters > 3 > income Statement > net Income
-279
Quarters > 3 > income Statement > eps
-0.00003255162758137907
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
8571000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1351
Quarters > 3 > balance Sheet > short Term Investments
1349
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
4.99
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
550.82
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
662.32
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
795.67
Quarters > 3 > balance Sheet > equity
-244
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-279
Quarters > 3 > cash Flow > depreciation
279.88
Quarters > 3 > cash Flow > change In Working Capital
69880
Quarters > 3 > cash Flow > cash From Operations
-106
Quarters > 3 > cash Flow > capital Expenditures
4
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-638
Quarters > 3 > cash Flow > net Change In Cash
-744
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.00003255162758137907
Quarters > 3 > ratios > PB
-364267.5
Quarters > 3 > ratios > ROE
114.34426229508196
Quarters > 3 > ratios > ROA
-50.65175556443121
Quarters > 3 > ratios > FCF
-110
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
479.73
Annuals > 0 > income Statement > operating Income
-479
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-479
Annuals > 0 > income Statement > net Income
-479
Annuals > 0 > income Statement > eps
-0.00005588612763971532
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
8571000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
1351
Annuals > 0 > balance Sheet > short Term Investments
1349
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
4991
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
550.82
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
662.32
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
795.67
Annuals > 0 > balance Sheet > equity
-244
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-479
Annuals > 0 > cash Flow > depreciation
479.73
Annuals > 0 > cash Flow > change In Working Capital
132.48
Annuals > 0 > cash Flow > cash From Operations
-172265
Annuals > 0 > cash Flow > capital Expenditures
5
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
173616
Annuals > 0 > cash Flow > net Change In Cash
1351
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.00005588612763971532
Annuals > 0 > ratios > PB
-364408.0081967213
Annuals > 0 > ratios > ROE
196.31147540983608
Annuals > 0 > ratios > ROA
-86.96125776115609
Annuals > 0 > ratios > FCF
-172270
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
38
Valuation > metrics > PE
0.094981
Valuation > metrics > PB
-32.54591886512977
Valuation > final Score
70
Valuation > verdict
99.1% Undervalued
Profitability > metrics > ROE
-29.80948813624774
Profitability > metrics > ROA
7747.77628032345
Profitability > final Score
45
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-0.10771010993086536
Risk > final Score
30
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.09317203252892213
Liquidity > metrics > Quick Ratio
0.09317203252892213
Liquidity > final Score
15
Liquidity > verdict
Weak
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
50
Prev Profitabilities > 0
47
Prev Profitabilities > 1
46
Prev Profitabilities > 2
55
Prev Risks > 0
60
Prev Risks > 1
59
Prev Risks > 2
50
Prev Liquidities > 0
27
Prev Liquidities > 1
28
Prev Liquidities > 2
10
Updated At
2026-01-20T21:43:02.824Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.0652
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.07
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-20
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.05
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.03
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.03
Earnings History > 3 > surprise Percent
-
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMarket Rankings: How liquid is PHX Minerals Inc stock - Portfolio Performance Summary & Free Verified High Yield Trade Plans baoquankhu1.vn
Read more →What’s Incannex Healthcare Inc.’s historical return - July 2025 Price Swings & AI Driven Stock Movement Reports baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Drugs Made In America Acquisition Corp. Ordinary Shares
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.0652
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.